Bio: Mara Aspinall is a healthcare industry leader and pioneer. Aspinall is President and CEO of Health Catalysts, an investment and advisory firm. Health Catalysts’ focus is diagnostic and health information technology firms, publishing the popular Health Catalysts Diagnostics Year in Review. Aspinall is also Executive Chairman of GenePeeks, a computational genomic information company.
Aspinall is a member of the Board of Allscripts (MDRX), OraSure (OSUR), Abcam plc (ABC), 3Scan, Blue Cross Blue Shield Arizona, Castle Biosciences. Aspinall is former President and CEO of Ventana Medical Systems, a division of the Roche Group, worldwide leader in development and commercialization of tissue-based cancer diagnostics. Previously, Aspinall spent 12 years as President of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics was sold to LabCorp for $1 billion. Aspinall was also Founder and CEO of On-Q-ity, a circulating tumor cells company.
With a passion for the importance of education, Aspinall co-founded the Arizona State University School of Biomedical Diagnostics, the first and only School dedicated entirely to Diagnostics as an independent discipline. The School awarded their first Master degrees in 2015 and will graduate 50 Master’s students this year.
Aspinall holds an MBA from Harvard Business School and a BA in International Relations from Tufts University.